Through the investigation of the GSE33814 dataset, we discovered that CDKN1B and NDUFA4 expressions were reduced in NAFLD, whereas TFAM expression was elevated (Figures 7D–F). Here, COXFA4 is linked to metabolic dysfunction-associated steatotic liver disease.